CompletedPhase 2NCT01020968
Use of Ixmyelocel-T (Formerly Catheter-based Cardiac Repair Cell [CRC]) Treatment in Patients With Heart Failure Due to Dilated Cardiomyopathy
Studying Dilated cardiomyopathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Vericel Corporation
- Principal Investigator
- Timothy Henry, MDMinneapolis Heart Institute Foundation
- Intervention
- Ixmyelocel-T(biological)
- Enrollment
- 22 enrolled
- Eligibility
- 18-86 years · All sexes
- Timeline
- 2009 – 2013
Study locations (3)
- Minneapolis Heart Institute, Minneapolis, Minnesota, United States
- University Hospitals, Case Western Reserve University, Cleveland, Ohio, United States
- University of Utah, Salt Lake City, Utah, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01020968 on ClinicalTrials.govOther trials for Dilated cardiomyopathy
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07137338A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated CardiomyopathyRocket Pharmaceuticals Inc.
- RECRUITINGNCT07293338Prognostic Values of Coronary Microvascular Dysfunction in Patients With Dilated CardiomyopathySecond Affiliated Hospital, School of Medicine, Zhejiang University
- RECRUITINGPHASE1NCT07241104A Study of AZD4063 in PLN R14del Dilated CardiomyopathyAstraZeneca
- RECRUITINGNANCT07359690Multimodal Analysis of Endomyocardial BiopsiesUniversity Hospital, Essen
- RECRUITINGPHASE1NCT06464588A Phase 1 Open-Label Study of the Safety of Intravenous Allogeneic Neonatal Mesenchymal Cells (nMSCs) in Young Adult (1A) and Pediatric (1B) Patients With Dilated Cardiomyopathy (DCM)Emory University
- RECRUITINGNANCT06922851Protein A Immunoadsorption in Dilated Cardiomyopathy (RPIA-DCM)Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- RECRUITINGNCT06741995Evaluating the Prognostic Impact of Anti-β1AR Antibodies and Anti-L-CaC Antibodies in Patients With Dilated CardiomyopathyUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology
- RECRUITINGNANCT06688396Dilated Cardiomyopathy Detection Using AI and Screening With Mobile Technology (DCM-DETECT)Lancaster General Hospital